How severe is CVE-2024-11660?

CVE-2024-11660 has a CVSS 3.x base score of 3.5, rated low severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.

Is CVE-2024-11660 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (42nd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2024-11660?

CVE-2024-11660 affects Anisha Farmacia. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2024-11660?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2024-11660 have an EU (EUVD) identifier?

Yes. CVE-2024-11660 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-33938.

When was CVE-2024-11660 published?

CVE-2024-11660 was published on 2024-11-25 and last updated on 2026-06-17.

CVE-2024-11660

CVE-2024-11660 is a low-severity vulnerability in Anisha Farmacia with a CVSS 3.x base score of 3.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Low (CVSS 3.x base score 3.5)
CVSS v2: 4.0
CVSS v4: 5.3
EPSS exploit prediction: 1% (42nd percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-33938
Weakness: CWE-79
Affected product: Anisha Farmacia
Published: 2024-11-25
Last modified: 2026-06-17

Description

A vulnerability was found in code-projects Farmacia 1.0. It has been classified as problematic. This affects an unknown part of the file usuario.php. The manipulation of the argument name leads to cross site scripting. It is possible to initiate the attack remotely. The exploit has been disclosed to the public and may be used. Other parameters might be affected as well.

Frequently asked questions

What is CVE-2024-11660?: A vulnerability was found in code-projects Farmacia 1.0. It has been classified as problematic. This affects an unknown part of the file usuario.php. The manipulation of the argument name leads to cross site scripting. It is possible to initiate the attack remotely. The exploit has been disclosed to the public and may be used. Other parameters might be affected as well.
How severe is CVE-2024-11660?: CVE-2024-11660 has a CVSS 3.x base score of 3.5, rated low severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.
Is CVE-2024-11660 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (42nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-11660?: CVE-2024-11660 affects Anisha Farmacia. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-11660?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-11660 have an EU (EUVD) identifier?: Yes. CVE-2024-11660 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-33938.
When was CVE-2024-11660 published?: CVE-2024-11660 was published on 2024-11-25 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:anisha:farmacia:1.0:*:*:*:*:*:*:*

More vulnerabilities in Anisha Farmacia

CVE-2024-12492 — Medium (CVSS 6.3): A vulnerability was found in code-projects Farmacia 1.0. It has been rated as critical. This issue affects some unknown…
CVE-2024-11968 — Medium (CVSS 6.3): A vulnerability was found in code-projects Farmacia up to 1.0. It has been declared as critical. Affected by this…
CVE-2024-11245 — Medium (CVSS 6.3): A vulnerability, which was classified as critical, has been found in code-projects Farmacia 1.0. This issue affects…
CVE-2024-11244 — Medium (CVSS 6.3): A vulnerability classified as critical was found in code-projects Farmacia 1.0. This vulnerability affects unknown code…
CVE-2024-11997 — Low (CVSS 3.5): A vulnerability was found in code-projects Farmacia 1.0. It has been classified as problematic. This affects an unknown…
CVE-2024-11996 — Low (CVSS 3.5): A vulnerability was found in code-projects Farmacia 1.0 and classified as problematic. Affected by this issue is some…

All CVEs affecting Anisha Farmacia →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →